Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22473769 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: bapineuzumab;   Other: placebo

Indicates status has not been verified in more than two years